- Home
- BCLI vs ILAG Comparison
BCLI vs ILAG Comparison
Compare BCLI & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- ILAG
- Stock Information
- Founded
- BCLI 2000
- ILAG 1981
- Country
- BCLI United States
- ILAG Hong Kong
- Employees
- BCLI N/A
- ILAG N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- ILAG Office Equipment/Supplies/Services
- Sector
- BCLI Health Care
- ILAG Consumer Discretionary
- Exchange
- BCLI Nasdaq
- ILAG Nasdaq
- Market Cap
- BCLI 9.9M
- ILAG 14.4M
- IPO Year
- BCLI N/A
- ILAG 2022
- Fundamental
- Price
- BCLI $1.73
- ILAG $0.83
- Analyst Decision
- BCLI Strong Buy
- ILAG
- Analyst Count
- BCLI 1
- ILAG 0
- Target Price
- BCLI $30.00
- ILAG N/A
- AVG Volume (30 Days)
- BCLI 41.1K
- ILAG 12.4K
- Earning Date
- BCLI 03-31-2025
- ILAG 04-14-2025
- Dividend Yield
- BCLI N/A
- ILAG N/A
- EPS Growth
- BCLI N/A
- ILAG N/A
- EPS
- BCLI N/A
- ILAG N/A
- Revenue
- BCLI N/A
- ILAG $8,980,747.00
- Revenue This Year
- BCLI N/A
- ILAG N/A
- Revenue Next Year
- BCLI N/A
- ILAG N/A
- P/E Ratio
- BCLI N/A
- ILAG N/A
- Revenue Growth
- BCLI N/A
- ILAG 33.03
- 52 Week Low
- BCLI $1.05
- ILAG $0.35
- 52 Week High
- BCLI $11.85
- ILAG $1.35
- Technical
- Relative Strength Index (RSI)
- BCLI 40.62
- ILAG 49.70
- Support Level
- BCLI $1.69
- ILAG $0.73
- Resistance Level
- BCLI $1.93
- ILAG $0.84
- Average True Range (ATR)
- BCLI 0.11
- ILAG 0.08
- MACD
- BCLI -0.00
- ILAG 0.01
- Stochastic Oscillator
- BCLI 16.67
- ILAG 79.70
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.